Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
ranexa 500 mg retardtabletten
a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - l'angine de poitrine - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
ranexa 750 mg retardtabletten
a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 750 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 2.29 mg, Überzug: triacetinum, hypromellosum, lactosum monohydricum 12 mg, cera carnauba, e 171, e 102 40 µg, e 133, pro compresso obducto. - l'angine de poitrine - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
xelevia 25 mg comprimés pelliculés
a. menarini ag - sitagliptinum - comprimés pelliculés - sitagliptinum 25 mg ut sitagliptini phosphas monohydricus, excipiens pro compresso obducto. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
xelevia 50 mg comprimés pelliculés
a. menarini ag - sitagliptinum - comprimés pelliculés - sitagliptinum 50 mg ut sitagliptini phosphas monohydricus, excipiens pro compresso obducto. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
xelevia 100 mg comprimés pelliculés
a. menarini ag - sitagliptinum - comprimés pelliculés - sitagliptinum 100 mg ut sitagliptini phosphas monohydricus, excipiens pro compresso obducto. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
velmetia 50/500 mg comprimés pelliculés
a. menarini ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg à sitagliptini phosphas monohydricus, metformini hydrochloridum 500 mg, excipiens pro compresso de la brume. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
velmetia 50/850 mg comprimés pelliculés
a. menarini ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg à sitagliptini phosphas monohydricus, metformini hydrochloridum 850 mg, excipiens pro compresso de la brume. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
velmetia 50/1000 mg comprimés pelliculés
a. menarini ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg à sitagliptini phosphas monohydricus, metformini hydrochloridum 1000 mg, excipiens pro compresso de la brume. - antidiabétique oral utilisé - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
bilaxten 20 mg comprimés
a. menarini gmbh - bilastinum - comprimés - bilastinum 20 mg, cellulosum microcristallinum, carboxymethylamylum natricum, silica colloidalis hydrica, magnesii stearas, pro compresso corresp. natrium 42 µg. - médicament antiallergique / antihistaminique - synthetika
Elveția -
franceză -
Swissmedic (Swiss Agency for Therapeutic Products)
vascord hct 20/5/12.5mg comprimés pelliculés
a. menarini gmbh - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - comprimés pelliculés - olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas, hydrochlorothiazidum 12.5 mg, amylum pregelificatum, cellulosum microcristallinum silicificatum, carmellosum natricum conexum corresp. natrium 0.96 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - hypertonie - synthetika